The Supreme Court has asked the government and the Central Board of Direct Taxes to respond to Serum Institute of India's appeal. This appeal challenges a 2015 amendment to the Income Tax Act, which made various subsidies and incentives taxable. The Serum Institute argues that taxing these capital receipts is constitutionally impermissible.
